arrow
N

Naleen Raj Bhandari

Eli Lilly and Company
H指数:12
被引数:676

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

How Many Lines of Therapy Do Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receive in Routine Clinical Practice in the United States? Real World Evidence from the Targeted Therapy Era

在美国常规临床实践中,慢性淋巴细胞白血病/小淋巴细胞淋巴瘤患者接受了多少线治疗?靶向治疗时代的真实世界证据

2026-10-140
OA
Patient-reported outcomes among patients with mantle cell lymphoma or chronic lymphocytic leukemia receiving pirtobrutinib in the BRUIN phase 1/2 study: final analysis

在BRUIN 1/2期研究中,接受pirto Brutinib治疗的套细胞淋巴瘤或慢性淋巴细胞白血病患者报告结局的最终分析

2026-01-010
PRE
Continuity of care for patients with chronic lymphocytic leukemia: an analysis of real-world data

Gabella S,Khanal M,Chen Y,Bhandari NR,Winfree KB,Abhyankar S,等。慢性淋巴细胞白血病患者护理连续性:真实世界数据分析。J Med Econ. (2025) 28:1500–11. doi: 10.1080/13696998.2025.2554514

2025-12-312
OAAI
Concurrent Penile Prosthesis and Artificial Urinary Sphincter versus Penile Prosthesis and Male Sling: A National Multi-Institutional Analysis of National Surgical Quality Improvement Program Database Comparing Postoperative Morbidity

并发阴茎假体和人工尿道括约肌与阴茎假体和男性吊带: 国家手术质量改进计划数据库的国家多机构分析,比较术后发病率

2021-01-013
OAAI